Clinical Trial Update: Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of DE-117 ophthalmic solution in open-angle glaucoma or ocular hypertension completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117 Ophthalmic Solution (DE-117)

Snippet

Sponsor: Santen Inc. | Conditions: Open-angle Glaucoma or Ocular Hypertension | Phase 2 | Status: COMPLETED